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Abstract
Primordial follicle assembly is a process that occurs when oocyte nests break down to form individual primordial follicles.
The size of this initial pool of primordial follicles in part determines the reproductive lifespan of the female. Connective
tissue growth factor (CTGF) was identified as a potential regulatory candidate for this process in a previous microarray
analysis of follicle development. The current study examines the effects of CTGF and associated transforming growth factor
beta 1 (TGFb-1) on follicle assembly. Ovaries were removed from newborn rat pups and placed in an organ culture system.
The ovaries treated with CTGF for two days were found to have an increased proportion of assembled follicles. CTGF was
found to regulate the ovarian transcriptome during primordial follicle assembly and an integrative network of genes was
identified. TGFb-1 had no effect on primordial follicle assembly and in combination with CTGF decreased oocyte number in
the ovary after two days of culture. Over ten days of treatment only the combined treatment of CTGF and TGFb-1 was found
to cause an increase in the proportion of assembled follicles. Interestingly, treatment with TGFb-1 alone resulted in fewer
total oocytes in the ovary and decreased the primordial follicle pool size after ten days of culture. Observations indicate that
CTGF alone or in combination with TGFb-1 stimulates primordial follicle assembly and TGFb-1 can decrease the primordial
follicle pool size. These observations suggest the possibility of manipulating primordial follicle pool size and influencing
female reproductive lifespan.
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Introduction
Oocytes in newborn rodents are present in ‘nests’ that are
composed of many adjacent oocytes with no intervening cells. Follicle
assemblyoccursinthefirstfewdaysafterbirthin rodents.In humans,
follicle assembly begins during mid-gestation near week 18 and
continues into the third trimester [1,2]. During the developmental
process of follicle assembly primordial follicles are formed from
oocyte nests [3,4,5,6,7]. The reproductive lifespan of a female is
determined in part by the sizeof the primordialfollicle pool generated
[8]. Initially in the embryonic ovary oogonia undergo mitotic
proliferation and then enter the first meiotic division to become
oocytes. These unassembled oocytes are present directly adjacent to
one another in nest structures which are surrounded by somatic cells
(i.e. precursor granulosa cells) [3,4,5,6,7,9]. The process of follicle
assembly results in the breakdown of oocyte nests, due partially to
apoptotic cell death of many of the oocytes. Somatic cells move into
the nests and intersperse between the remaining oocytes [10,11,12].
An oocyte must be surrounded by an adequate number of pre-
granulosa cells to form a primordial follicle [13,14,15]. The
primordial follicles formed constitute a pool of follicles having oocytes
arrested in prophase I of meiosis [3,4,5,6]. Primordial follicles
gradually leave the arrested pool by undergoing the primordial to
primary follicle transition. After transition follicles as they grow either
undergo apoptosis/atresia or the follicles ovulate. In humans, when
the pool of follicles is depleted reproduction ceases and women enter
menopause [16,17,18,19,20]. Some studies have suggested the
possibility that new follicles with oocytes may form in adulthood
[21,22,23], but the preponderance of literature suggests that a defined
and finite pool of primordial follicles exists [24]. It is possible that if
the size of the follicle pool could be manipulated the reproductive
capacity and fertile lifespan of the organism may change.
Although several signal transduction and transcription factors
have been shown to influence the primordial follicle pool
[25,26,27,28,29], few extracellular signaling factors have been
shown to have an effect on ovarian follicle assembly. Treatment of
neonatal mice with activin resulted in an increase in the initial pool
size [30]. It has been shown that both estrogen and progesterone
slow the rate of follicle assembly [31]. This study also demon-
strated that progesterone acts at least in part through an inhibition
of oocyte apoptosis. Previous studies have demonstrated that
apoptosis of oocytes is part of follicle assembly [9,32]. The actions
of progesterone were later found to be inhibited by tumour
necrosis factor-alpha (TNFa) [33]. TNFa did not have an effect on
the rate or percentage of assembled follicles, but promoted the
apoptosis of oocytes. TNFa was found to block the inhibitory
actions of progesterone and promote normal primordial follicle
assembly [33]. Analysis of the inhibitory actions of progesterone
on follicle assembly using a microarray analysis of the ovarian
transcriptome demonstrated that progesterone promoted a
dramatic up-regulation of connective tissue growth factor (CTGF),
as well as an increase in the TGFb family member TGFb-3 [33].
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in primordial follicle assembly due to its altered gene expression
during this process [33,34]. Connective tissue growth factor
(CTGF) has been shown to be expressed by multiple cell types and
to have numerous functions. CTGF is well known for its roles in
tissue remodeling [35] and extra-cellular-matrix formation [36].
Tissue remodeling and extracellular matrix are important for
follicular development [37]. CTGF is the most studied member of
the CCN family of proteins, which is composed of cysteine-rich
protein 61 (CYR61, CCN1), CTGF (CCN2), nephroblastoma
overexpressed gene (NOV, CCN3), and Wnt-inducible secreted
proteins 1–3 (WISP-1, WISP-2, WISP-3), which are also known as
CCN4 through CCN6 [38]. CTGF mRNA has been shown to be
present in ovaries in pre-antral to preovulatory follicles in both rats
and pigs [39,40]. CTGF and transforming growth factor-beta
(TGFb-1) have been shown to modify the functions of each other.
For instance, CTGF regulates connective tissue fibroblasts [41]
and vascular smooth muscle cells [42] through a modulation of
TGFb-1 actions.
Transforming growth factor beta-one (TGFb-1) has been shown
to be present in both rat and human ovaries during follicle
assembly [43,44]. TGFb-1, TGFb-2, and TGFb-3 are known to
be expressed throughout adulthood in ovarian follicles. TGFbs
have been shown to stimulate oocyte meiotic maturation in
pubertal 23–25 day old rats [45]. In humans, TGFb-1 has been
localized primarily to oocytes during the period from 18–22 weeks
of gestation [44]. In contrast, in 1–3 day old rats, TGFb-1 has
been localized primarily to granulosa cells [43]. The role of TGFb-
1 in neonatal ovary development has not been determined.
The present study is designed to determine if CTGF and/or
TGFb-1 affect the process of follicle assembly or alter primordial
pool size. Since the expression of CTGF changes during follicle
assembly, as shown in recent microarray studies [33,34], the
functional role of CTGF was investigated. Interestingly, CTGF
was found to induce primordial follicle assembly while TGFb
reduced primordial follicle pool size.
Materials and Methods
Histology and Organ Cultures
Harlan Sprague-Dawley rats from Washington State University
breeder colonies were used in this study. Female rat pups
(,8 hours old) were euthanized and their ovaries were dissected.
All procedures were approved by the Washington State University
Animal Use and Care Committee (IACUC approval # 02568-
014). Whole ovaries were cultured as previously described [46] on
floating filters (.4 mm Millicell-CM, Millipore, Bedford, MD, USA)
in .5 ml Dulbecco’s modified Eagle’s medium (DMEM)-Ham’s F-
12 medium (1:1, vol/vol) containing 0.1% BSA (Sigma), 0.1%
Albumax (Gibco BRL, Gaithersburg, MD, USA), 27.5 mg/ml
transferrin, and 0.05 mg/ml L-ascorbic acid (Sigma) in a four-well
culture plate (Nunc plate, Applied Scientific, South San Francisco,
CA, USA) for two or ten days. The medium was supplemented
with penicillin and streptomycin to prevent bacterial contamina-
tion. Ovaries were randomly assigned to treatment groups, with 1–
3 ovaries per floating filter. Wells were treated every two days with
recombinant connective tissue growth factor (CTGF) (Peprotech,
Rocky Hill, NJ, USA) at 500 ng/ml, transforming growth factor
beta 1 (TGFb-1) (R&D Systems, Minneapolis, MN, USA) at
50 ng/ml, a combination of both CTGF and TGFb-1, or
progesterone (P4) (Sigma) at 10
26 M. After culture, ovaries were
fixed in Bouin’s fixative (Sigma) for two hours. Ovaries were then
embedded in paraffin, sectioned at 3 mm and stained with
hematoxylin/eosin for use in morphological analysis.
Morphological Analysis
The number of oocytes at each developmental stage was
counted and the number for each developmental stage was
averaged across two consecutive sections that had the largest
ovarian cross section. The oocyte nucleus had to be visible for an
oocyte to be counted. Normally, between 100 and 300 oocytes
were present in each cross-section. Oocytes were microscopically
examined and were classified as being not yet assembled into
follicles (i.e. the oocyte was part of an unassembled oocyte nest), as
primordial (stage 0) or as one of the developing pre-antral stages
(stages 1–4) as described previously [31,47]. Unassembled oocytes
are recognized from being grouped together without any
intervening stromal cells. As assembly occurs, the surrounding
pre-granulosa cells and the developing basement membrane
around the follicle provide a more distinct and visible division of
one oocyte from another. Primordial follicles consist of an oocyte
partially or completely surrounded by a single layer of squamous
pre-granulosa cells. Developing (stages 1–4) follicles contain
successively more cuboidal granulosa cells in layers around the
oocyte [4,5,46,47]. Total oocyte numbers per ovarian cross-section
were divided by the area (mm
2) of the cross-section to account for
any differences in ovary size between individuals.
Apoptosis Assay
The degree of oocyte atresia (i.e. apoptosis) was measured with
the in situ cell death detection kit (Roche Applied Science,
Indianapolis, IN). Briefly, neonatal ovaries were cultured for 2
days, at which time follicular assembly is readily observed. Then
cultured ovaries were fixed, embedded in paraffin, and sectioned.
Paraffin embedded slides were then treated as per instructions in
the apoptosis detection kit. Use of terminal deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate nick end-labeling
(TUNEL) in situ caused polymerization of fluorescein-labeled
nucleotides to the free 39 ends of DNA that had been cleaved
during apoptosis. Therefore, fluorescein-stained cellular nuclei had
multiple breaks in their DNA and were undergoing apoptosis at
the time of fixation.
Immunohistochemistry
Ovary sections from cultured postnatal day 0 (P0) ovaries
(cultured for 2 days) were immunostained as described previously
[48], for the presence of CTGF using anti-CTGF primary
antibody (anti-CTGF rabbit IgG, 1 mg/ml; Santa Cruz Biotech-
nology, Santa Cruz, CA, USA). Briefly, 3 mm sections were
deparaffinized, rehydrated through a graded ethanol series, boiled
in 10 mM sodium citrate buffer, quenched in 3% hydrogen
peroxide/20% methanol and 0.1% Triton-X solution, and then
blocked with 10% goat serum (normal goat serum; Vector
Laboratories Inc., Burlingame, CA, USA) for 20 min prior to
incubation with 1 mg/ml CTGF antibody (R&D Systems) for 12 h
at 4uC. The sections were then washed with PBS and incubated
with 1:300 diluted biotinylated secondary antibody for 45 min
(goat anti-rabbit IgG; Vector Laboratories Inc.), washed again,
and incubated with streptavidin peroxidase (Zymed, San Fran-
cisco, CA, USA) prior to color development with a DAB
peroxidase substrate kit (Vector Laboratories Inc). Following
development, the sections were dehydrated, coverslips mounted
with xylene-based medium (Cytoseal-XYL; Richard Allan Scien-
tific, Kalamazoo, MI, USA), and analyzed at 2006, 4006, and
10006 magnification using light microscope. Negative control
experiments were performed using a non-specific primary
antibody at 1 mg/ml (rabbit IgG; Sigma) and a negative control
of an irrelevant anti-SRY antibody at 1 mg/ml (anti-SRY rabbit
IgG, 1 mg/ml; Santa Cruz Biotechnology, Santa Cruz, USA).
Primordial Follicle Assembly
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Samples of 2–3 pooled control on treated ovaries were stored in
TRIZOL (Invitrogen) at –80uC until RNA extraction following
the manufacturer’s protocol. High quality RNA samples were
assessed with gel electrophoresis and required a minimum
OD260/280 ratio of 1.8. Three samples each of control and treated
ovaries were applied to microarrays.
Microarray Analysis
mRNA processing and hybridization were performed at
Genomics Core Laboratory, Center for Reproductive Biology,
Washington State University, Pullman, WA using standard
Affymetrix reagents and protocol. Briefly, mRNA was transcribed
into cDNA with random primers, from the later, cRNA was
transcribed, and from that, single-stranded sense DNA was
synthesized which was fragmented and labeled with biotin.
Biotin-labeled fragmented ssDNA was then hybridized to the
Rat Gene 1.0 ST microarrays containing more than 27,000
transcripts (Affymetrix, Santa Clara, CA, USA). Hybridized chips
were scanned on Affymetrix Scanner 3000. CEL files containing
raw data were then pre-processed and analyzed with Partek
Genomic Suite 6.5 beta software (Partek Incorporated, St. Louis,
MO) using RMA, GC-content adjusted algorithm. The signals
from 11 probe sets for each transcript were combined to give a
single value. Lists of differentially expressed genes treatment were
generated using following cut off criteria: signal ratio Control/
Treatment .1.20 or ,0.83, mean difference for un-logged signals
between control and treatment .10, t-test p-values ,0.05. p-
values were generated in 2-way ANOVA, blocking for organ
culture date batch effects.
CEL files (MIAME compliant raw data) from this study have
been deposited with the NCBI gene expression and hybridization
array data repository (GEO, http://www.ncbi.nlm.nih.gov/geo,
#GSE22096) and can be also accessed through www.skinner.
wsu.edu. For genes annotation, Affymetrix annotation file
RaGene1_0stv1.na30.rn4.transcript.csv was used unless otherwise
specified. Generation of affected KEGG pathways (Kyoto
Encyclopedia for Genes and Genome, Kyoto University, Japan)
used Pathway-Express, a web-based tool freely available as part of
the Onto-Tools (http://vortex.cs.wayne.edu) [49].
Previous studies have demonstrated that microarray data are
validated with quantitative PCR data [34,50]. Due to the presence
of 11 different oligonucleotide sets for each specific gene being
used on the microarray versus only a single primer set for a gene in
a quantitative PCR, the microarray is more effective at eliminating
false positive or negative data and provides a more robust
quantification of changes in gene expression.
Statistical Analysis
Treatment groups are compared using analysis of variance
(ANOVA) followed by comparative t-tests where appropriate.
Groups were considered statistically significant with P#0.05. All
statistics were calculated using GraphPad Prism version 5.0b for
Macintosh, GraphPad Software, San Diego, CA, USA.
Results
Data from a previous microarray and ovarian transcriptome
analysis demonstrated the relative expression of TGFb-1, 2, and 3
were highest in unassembled oocytes [34]. The inhibitory actions
of progesterone on primordial follicle assembly was found to
coincide with a dramatic increase in CTGF gene expression [33].
CTGF and TGFb-3 are secreted growth factors that showed a
stimulation by progesterone during follicle assembly. TGFb-3 and
TGFb-1 bind to the same receptor, but only TGFb-1 was
commercially available. Therefore, CTGF and TGFb-1 were
selected as candidates to investigate experimentally as being
involved in the regulation of primordial follicle assembly.
The 0-day old rat ovary is composed almost entirely of nests of
unassembled oocytes (Figure 1A). In the rodent by 4 days of age
the follicle assembly process is in large part completed, and the
oocytes have assembled into primordial follicles (Figure 1B, 1C).
Therefore, the ovaries can be caught in an intermediate stage of
assembly by using 0 day ovaries and culturing for 2 days. Ovaries
from newborn 0-day-old rat pups were placed onto a floating filter
organ culture system and treated with either 50 ng/ml transform-
ing growth factor beta one (TGFb-1), or 500ng/ml connective
tissue growth factor (CTGF), or a combination of TGFb-1 and
CTGF, or 10
26M progesterone (P4), or were left untreated as
controls. After two days of culture, the ovaries were fixed,
sectioned and stained for morphological analysis. The relative
proportion of assembled follicles was compared across treatment
groups (Figure 2A). Treatment with CTGF was found to
significantly increase the percentage of assembled follicles. As
seen in previous studies [31], progesterone decreased the
proportion of assembled follicles over 2 days. Response to
progesterone was used as a positive control for these experiments.
TGFb-1 had no effect alone. The combined treatment of CTGF
and TGFb-1 was not different from CTGF alone. Observations
indicate the presence of TGFb-1 did not have a direct effect on the
percentage of assembled follicles (Figure 2A).
For each ovary section counted the cross sectional area was
determined using ImageJ [51]. The total number of oocytes in
each ovary was normalized by its area (mm
2) and the oocyte
density for each ovary compared between treatment groups
(Figure 2B). There was no difference in ovarian cross-sectional
area between treatment groups (data not shown). Interestingly, the
combined CTGF and TGFb-1 treatment significantly decreased
the oocyte density compared to controls. No other treatment
groups had any significant effect. Therefore, the combination of
CTGF and TGFb-1 appeared to decrease the initial oocyte
cohort/pool in the ovary after two days of culture.
Oocyte apoptosis was investigated since the primordial follicle
assembly process involves programmed cell death of the oocytes.
The level of apoptosis was measured with TUNEL assays of DNA
fragmentation. The number of apoptotic oocytes per section for
each treatment group were compared (Figure 3). No significant
alteration in oocyte apoptosis was observed in any treatment
group. Therefore, the actions of CTGF did not appear to involve
altered oocyte apoptosis at 2 days of culture.
The effects of the growth factors on the primordial follicle pool
size used a 10-day ovary culture system. The combined treatment
of CTGF and TGFb-1 was found to increase the proportion of
assembled primordial follicles and decrease the proportion of
unassembled follicles (Figure 4B and 4C). Progesterone (P4) was
found to decrease the percentage of assembled and developed
follicles (Figure 4A and 4B) and increase the percentage of
unassembled follicles compared to controls (Figure 4C). The
unassembled follicles present were small clusters of 2–3 oocytes as
shown in Figure 1D. The oocyte density and ovarian cross-
sectional area in each ovary were compared across treatments
(Figure 5). The TGFb-1 treatment group showed a significant
decrease in the number of oocytes (Figure 5A). In contrast, the
total ovary section area (i.e. size) was not affected by any treatment
(Figure 5B). The effects of P4 and CTGF on the 10-day cultures
appeared to be due to altered unassembled follicle populations and
not a change in pool size. However, the effects of TGFb1 alone
appears to be due to a reduced follicle pool size.
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that had been cultured for two days to determine where CTGF
was localized (Figure 6). CTGF was localized to the basement
membranes of both nests and more developed follicles. As ovaries
in culture undergo growth and development it is expected that the
cell type distribution of ligand and receptor will be similar to that
in vivo [39,40]. Therefore CTGF appears to be localized to
basement membranes and expressed throughout the ovary.
Neither use of non-specific IgG as a primary antibody nor an
irrelevant anti-SRY antibody resulted in any specific staining in
the ovary.
The molecular actions of CTGF on primordial follicle assembly
were investigated with a microarray analysis of the ovarian
transcriptome. Ovaries from newborn 0-day-old rat pups were
cultured for 1 day of treatment prior to collection for analysis.
Morphological analysis of these ovaries demonstrated negligible
effects on follicle morphology and assembly after only 1 day of
treatment (data not shown). This allows an analysis of CTGF
actions on the ovarian transcriptome independent of morpholog-
ical changes to the ovary. CTGF was found to alter the expression
of 76 genes with 33 having an increase in expression and 43
having a decrease in expression. A list of these known genes in
their appropriate functional categories is presented in Table 1.
The presence of Cxcl2 suggests this chemokine may also be
involved in follicle assembly. Interestingly, several olfactory
receptors were found to be regulated in the ovary by CTGF
treatment, Table 1 and Supplemental Table S1. In addition, an
integrated gene network analysis demonstrated 11 regulated genes
from this list formed a gene network with appropriate interactions
with critical cellular processes (Figure 7). The most abundant
functional classes of regulated genes were cell differentiation, cell
cycle and apoptosis. Therefore, insights into the molecular actions
of how CTGF promotes follicle assembly are provided.
Discussion
Previous ovarian transcriptome analysis demonstrated that
TGFb-1 is highly expressed during the follicle assembly process
when compared to ovaries containing primordial or primary
follicles [34]. In addition, the ability of progesterone to inhibit
follicle assembly resulted in a dramatic increase in expression of
CTGF [33]. CTGF and TGFb-3 were among the few growth
factors shown to be regulated. TGFb-1 and TGFb-3 act on the
same receptor complex to stimulate the same signaling cascade.
CTGF and TGFb-1 are also known to regulate each others’
functions [41,42]. Therefore, CTGF and TGFb-1 were investi-
gated as potential regulators of primordial follicle assembly
utilizing whole ovary organ cultures.
Observations from the two-day ovary culture experiments
demonstrates that CTGF promotes primordial follicle assembly.
TGFb-1 treatment was not found to have an effect alone. The
combined treatment of CTGF and TGFb-1 stimulated follicular
assembly to the same degree as CTGF alone. Therefore, TGFb-1
had no effect on the proportion of oocytes assembled into follicles
after two days of culture. Treatment with progesterone (P4)
inhibited follicle assembly as previously described [31], and was
used as a positive control in these experiments. Analysis of oocyte
density demonstrated that the combined treatment of CTGF with
TGFb-1 induced a significant decrease in oocyte number. This
suggests that the two factors synergize to modify oocyte number
Figure 1. Follicle assembly in rat ovaries begins just after birth. Oocytes are initially present only in nests, with few or no intervening cells, (A)
and the left half of (C). The circle outlines in (A) indicate the locations of two nests. Follicle assembly results in many of these oocytes undergoing
apoptosis with the surviving oocytes developing into primordial follicles, indicated with arrows, (B) and the right half of (C). (A) P-0 ovary. (B) P-0 ovary
after culture for 2 days. (D) shows a zero day ovary that has been cultured for ten days and has much smaller nests that contain fewer oocytes,
indicated in circle.
doi:10.1371/journal.pone.0012979.g001
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pool size. One possible way to stimulate follicular or ovarian
development and decrease pool size is by increasing apoptosis of
the oocytes. This was tested with a cellular apoptosis assay, but no
significant effect of any treatment was demonstrated. Therefore,
CTGF and the combined CTGF & TGFb-1 treatment groups
appear not to act through altering apoptosis. However, it is
possible that a difference in apoptosis rates may not be detectable
at two days of culture. Further studies with shorter or longer
culture periods are needed to clarify if there is a period at which
CTGF and TGFb-1 affect apoptosis. Alternatively, CTGF may
modify the extra-cellular matrix (ECM) of either pre-granulosa
cells or the oocytes. In summary, after two days of ovary culture
CTGF was found to induce primordial follicle assembly while a
combined CTGF and TGFb-1 treatment initially reduced the pool
of oocytes in the ovary.
Morphologically, the basement membranes of the nests are
degraded and new membranes around primordial follicles are
formed during follicle assembly. This ECM formation and
breakdown is essential for follicular development [37]. CTGF
has previously been shown to affect ECM structure and stability in
other tissues [36]. CTGF was primarily localized to the ECM of
nest basement membranes and to the cell membranes of individual
oocytes. These results are consistent with the general sub-cellular
localization of CTGF in other tissues [36]. So one mechanism of
action for CTGF may be for CTGF to affect ECM during follicle
assembly, possibly promoting the cell migration that is a part of
primordial follicle formation [37].
Ovaries were also treated for ten days in culture to investigate
the possibility of manipulating the primordial follicle pool size at a
time near the end of follicle assembly. In the event the number of
assembled follicles could be affected with a growth factor
treatment, observations would indicate the possibility of affecting
the primordial follicle pool size and thus reproductive lifespan of a
female. The nests found after 10 days of treatment were markedly
smaller than nests after two days (Figure 2D). In vivo no
unassembled nests would be observed after 10 days of postnatal
development, but the ovary organ culture system has the capacity
to retain small nests of unassembled oocytes. After 10 days of
Figure 2. Effect of CTGF and TGFb-1 treatment on follicle
assembly in 0-day-old ovaries cultured for two days. (A) Effect of
CTGF, TGFb-1 and progesterone (P4) treatment on follicle assembly.
Data are presented as the percentage of assembled oocytes (mean 6
S.E.M.) pooled from eleven separate experiments (n=4–16 per
treatment group). One-way ANOVA showed a significant (P,0.005)
effect of treatment. Bars with asterisks indicate the P-value in
comparative pooled t-test vs. the control group. (*)P#0.05 and
(***)P#0.001. (B) Effect of CTGF and TGFb-1 treatment on oocyte
density in ovaries cultured for two days. The total number of oocytes in
each section was divided by the cross-sectional area of that ovary. Data
are presented as the oocytes per square millimeter (mm
2) (mean 6
S.E.M.) pooled from eleven separate experiments (n=4–16 per
treatment group). One-way ANOVA showed a significant (P,0.05)
effect of treatment. Bars with asterisks indicate the P-value in
comparative pooled t-test vs. the control group. (**)P#0.01.
doi:10.1371/journal.pone.0012979.g002
Figure 3. Effect of CTGF, TGFb-1 and progesterone (P4)
treatments on oocyte apoptosis in ovaries cultured for two
days. After culture ovaries were fixed, sectioned and an apoptosis
assay (TUNEL) performed on the sections. Data are presented as the
number of apoptotic cells per cross section (mean 6 S.E.M.) pooled
from four separate experiments (n=4–12 per treatment group). One-
way ANOVA showed no significant (P=.6746) effect of treatment.
doi:10.1371/journal.pone.0012979.g003
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follicles as was observed after two days of treatment. The likely
explanation for this is that CTGF only increases the rate of follicle
assembly. The control untreated ovaries appear to have ‘‘caught up’’
developmentally over the longer 10-day culture time period.
Interestingly, the combined treatment of both CTGF and
TGFb-1 was observed to increase the proportion of assembled
follicles over ten days. This suggests that CTGF and TGFb-1 act
synergistically to promote follicle development since the CTGF
treatment group alone did not have an effect after ten days of
culture. This also indicates this treatment may affect follicle
transition which takes place immediately after assembly. In
contrast, progesterone was seen to inhibit follicle assembly and
development over ten days [31]. Progesterone was found to
increase the proportion of unassembled follicles, and the combined
CTGF and TGFb-1 treatment decreased the proportion of
unassembled follicles. Therefore, the inhibitory effects of proges-
terone and stimulatory effects of the combined CTGF and TGFb-
1 treatment on primordial follicle assembly can be explained by
their respective actions on the unassembled follicle pool, even
Figure 4. Effect of CTGF and TGFb-1 treatments on follicle
assembly in ovaries cultured for ten days. Data are presented as
the percentage of (A) developing follicles (i.e. those that have
undergone follicle transition), (B) assembled follicles (which include
developing follicles), and (C) unassembled follicles (mean 6 S.E.M.)
pooled from six separate experiments (n=6–13 per treatment group).
One-way ANOVA showed a significant (P,0.05) effect of treatment. Bars
with asterisks indicate the P-value in comparative pooled t-test vs. the
control group. (*)P,0.05, (**)P,0.01.
doi:10.1371/journal.pone.0012979.g004
Figure 5. Effect of CTGF, TGFb-1 and progesterone (P4)
treatment on follicle assembly in ovaries cultured for ten days.
Data area presented as (A) the total number of oocytes per cross
sectional area (mm
2) or (B) total cross sectional area (mm
2) (mean 6
S.E.M.) pooled from six separate experiments (n=6–13 per treatment
group). One-way ANOVA showed a significant (P,0.05) effect of
treatments in (A). Bars with asterisks indicate the P-value in comparative
pooled t-test vs. the control group.
doi:10.1371/journal.pone.0012979.g005
Primordial Follicle Assembly
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separate actions of TGFb-1 and CTGF on follicle assembly appear
different than their combined effects. For example, TGFb-1 alone
decreased total oocyte number in 10-day ovary cultures, while
TGFb-1 plus CTGF did not. This suggests that their actions
combined are not simply the additive result of their separate
actions. It is likely that the synergism of signaling pathways from
both CTGF and TGFb regulate specific and novel cellular
functions.
Observations suggest the expression of progesterone, CTGF
and TGFb expression are coordinated with each other. Previous
studies of rat follicle assembly indicates progesterone treatment
of ovaries resulted in a 2.7-fold change in CTGF mRNA
expression, and a 1.6-fold change in TGFb-3 expression [33]. In
the current study microarray analysis revealed that CTGF
treatment resulted in a small (1.1-fold) but statistically significant
(p,0.05) increase in TGFb-3 expression. In other organ systems
it has been shown that CTGF and TGFb-1 modulate each
other’s expression and actions [41,42]. The signaling pathways
that link the expression suggest the assembly-inhibiting actions of
progesterone stimulates the expression of CTGF and TGFb’s
that in turn can promote follicle assembly. Observations suggest
the inhibition of follicle assembly may prime the factors that in
turn stimulate assembly.
The total number of oocytes per ovarian cross-section was
measured in the ten-day culture experiments. Interestingly, none
of the treatments that affected the percentage of assembled follicles
(i.e. CTGF and TGFb-1, or P4) resulted in a significantly different
number of oocytes when compared to controls. Therefore, the
altered percentage of primordial follicles was due to corresponding
alterations in the assembly of unassembled oocytes into primordial
follicles and not from altered oocyte number. However, TGFb-1
treatment was found to significantly reduce the total number of
oocytes per cross section compared to controls. Observations
indicate that TGFb-1 reduced the total oocyte number, such that
the actions of TGFb may reduce the future capacity for follicular
development. Although the postnatal alteration in oocyte number
suggests the possibility of manipulating the primordial follicle pool
and reproductive lifespan for a female, previous studies have
suggested that at puberty the primordial follicle pool may
normalize. For example, an increased number of assembled
follicles caused by activin treatment prepubertally was reduced to
normal levels during puberty [30]. Further studies are needed to
determine if the mechanisms involved during puberty com-
pensate for any earlier prepubertal primordial follicle pool size
manipulation.
Investigation of the molecular events involved in CTGF
induction of primordial follicle assembly used a microarray
Figure 6. Localization of CTGF in cultured ovaries. Ovaries were dissected from zero day old rat pups and cultured for two days.
Immunohistochemistry was performed on ovary sections. Only untreated ovaries were selected for this procedure. The primary antibodies used were
anti-CTGF (A), negative control non-specific goat IgG (B), and negative control anti-SRY IgG (C).
doi:10.1371/journal.pone.0012979.g006
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Gene Symbol GenBank_Reference Sequence mean_diff (CTGF-Con) Ratio CTGF/Con Gene Title
Apoptosis
Rybp NM_001107879 74 1.22 RING1 and YY1 binding protein
Cell Cycle
Egr1 NM_012551 26 1.20 early growth response 1
Cytoskeleton & ECM
Mybpc1 X90475 214 0.82 myosin binding protein C, slow type
Development
Id4 NM_175582 12 1.23 inhibitor of DNA binding 4
Tsx NM_019203 8 1.32 testis specific X-linked gene
Vgll1 XM_001058701 6 1.31 vestigial like 1 (Drosophila)
Epigenetics
Prmt2 NM_001025144 231 0.84 protein arginine methyltransferase 2
Growth Factors
Cxcl1 NM_030845 35 1.21 chemokine (C-X-C motif) ligand 1
(melanoma growth stimulating
activity, alpha)
Immune Response
LOC683127 XM_001064581 232 0.77 similar to CD209a antigen
Metabolism
Agxt2 NM_031835 14 1.54 alanine-glyoxylate aminotransferase 2
Ard1b NM_001024742 12 1.20 ARD1 homolog B (S. cerevisiae)
Pdia5 NM_001014125 26 1.33 protein disulfide isomerase family A,
member 5
Proteolysis
Spink5l1 NM_001008874 4 1.22 Kazal type serine protease inhibitor 1
Receptors & Binding Proteins
Ly49s6 NM_001009488 27 0.79 Ly49 stimulatory receptor 6
Olr1226 NM_001000442 210 0.84 olfactory receptor 1226
Olr46 NM_001001001 3 1.23 olfactory receptor 46
Olr630 NM_001001059 5 1.31 olfactory receptor 630
Olr684 NM_001001378 5 1.21 olfactory receptor 684
Olr690 NM_001000569 5 1.21 olfactory receptor 690
Olr727 NM_001000619 25 0.76 olfactory receptor 727
Olr901 NM_001000057 28 0.78 olfactory receptor 901
Olr920 NM_001001356 13 1.42 olfactory receptor 920
RGD1559730 AAHX01105426 27 0.78 similar to putative pheromone
receptor (Go-VN4)
Vom2r12 NM_001099488 23 0.83 vomeronasal 2 receptor, 12
Signaling
Cby1 NM_145676 223 0.78 chibby homolog 1 (Drosophila)
Gpr132 NM_001170595 6 1.22 G protein-coupled receptor 132
MGC109340 BC092634 225 0.83 similar to Microsomal signal
peptidase 23 kDa subunit (SPase
22 kDa subunit) (SPC22/23)
Minpp1 NM_019263 20 1.28 multiple inositol polyphosphate
histidine phosphatase 1
LOC690930 XM_001078213 25 0.84 similar to membrane-spanning 4-
domains, subfamily A, member 6B
Transcription
Dnaja4 NM_001025411 7 1.24 DnaJ (Hsp40) homolog, subfamily A,
member 4
Dnajc30 NM_001109024 216 0.72 DnaJ (Hsp40) homolog, subfamily C,
member 30
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CTGF impact numerous cellular processes with cell differentiation
and cell cycle being prominent. The gene network identified
suggested an extracellular growth factor (CXCL2), receptor
signaling (GPR132 and CTNNB1), numerous signaling systems
and transcriptional factors are all involved in primordial follicle
assembly, Figure 7. Numerous potential signal transduction
processes and families of transcription factors are regulated by
CTGF, Supplemental Tables 1 and S1. Clearly the cytokine
CXCL2 is a potential regulator of primordial follicle assembly that
needs to be investigated. Further information is needed before
specific pathways or transcription processes could be considered
for therapeutic targets. However, the molecular actions of CTGF
on primordial follicle assembly provide insights into this critical
developmental process.
In summary, experiments using postnatal day 0 cultured rat
ovaries were performed to determine the effects of CTGF and
TGFb-1 on primordial follicle assembly. CTGF alone was found
to stimulate primordial follicle assembly. Treatment with CTGF
and TGFb-1 together was found to stimulate follicle assembly.
Neither of these treatments were found to act through an apoptotic
pathway or alteration in oocyte number. Interestingly, TGFb-1
alone was found to decrease the number of oocytes and follicles
over ten days suggesting the possibility that primordial follicle pool
size may be manipulated. This treatment will need to be tested in
vivo to determine if the reproductive lifespan of females can be
manipulated. Understanding the processes of follicle assembly and
follicle transition could lead to therapies to prevent premature
ovarian failure or to the ability to manipulate the onset of
menopause. The current study identifies CTGF as one of the few
Gene Symbol GenBank_Reference Sequence mean_diff (CTGF-Con) Ratio CTGF/Con Gene Title
Hint1 BC168732 27 0.77 histidine triad nucleotide binding
protein 1
RGD1564534 BC111405 16 1.50 similar to CHCHD4 protein
Translation & Protein Modification
Eif1 NM_001105837 13 1.20 eukaryotic translation initiation
factor 1
Lin28 NM_001109269 31 1.21 lin-28 homolog (C. elegans)
LOC298509 XR_007384 26 0.82 similar to 60S ribosomal protein L21
LOC688243 ENSRNOT00000045033 26 0.82 similar to Nucleolin (Protein C23)
doi:10.1371/journal.pone.0012979.t001
Table 1. Cont.
Figure 7. Scheme of shortest connections to cellular processes for the 76 differentially expressed genes obtained by global
literature analysis (Pathway Studio, Ariadne). Only 11 connected genes from the list of 76 are shown – colored red or blue; the rest are not
connected and not shown. Red color represents up-regulated genes, blue color – down-regulated genes, grey color means that gene/protein is not
from the list of 76. Arrows with plus sign show positive regulation/activation, arrows with minus sign – negative regulation/inhibition; grey arrows
represent regulation, lilac - expression, and green - promoter binding. Node shapes code: oval and circle – protein; crescent – protein kinase and
kinase; diamond – ligand; irregular polygon – phosphatase; circle/oval on tripod platform – transcription factor; ice cream cone – receptor, rectangle -
cell processes.
doi:10.1371/journal.pone.0012979.g007
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assembly, and TGFb-1 as a factor that can reduce prepubertal
follicle pool size.
Supporting Information
Table S1 List of differentially expressed genes in rat P0-Ovary
under in vitro CTGF treatment (76 genes).
Found at: doi:10.1371/journal.pone.0012979.s001 (0.06 MB
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